Bacteriophages hold significant potential as biosensors and therapeutics, due to their highly specific host recognition elements and lysis mechanisms. Antimicrobial resistance is a looming threat in both food and healthcare settings and synthetic biology applied to bacteriophage holds an important role in stemming the tide. Hereinwe sought to engineer novel bacteriophage for application as biosensors and potential therapeutics through de-novo genome assembly.